Celldex Therapeutics, Inc. (CLDX)
34.51
+0.65
(+1.92%)
USD |
NASDAQ |
Apr 17, 16:00
34.50
0.00 (0.00%)
After-Hours: 20:00
Celldex Therapeutics Research and Development Expense (Quarterly) : 74.52M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 2.941M |
| Atossa Therapeutics, Inc. | 6.156M |
| Abeona Therapeutics, Inc. | 5.849M |
| Cell Source, Inc. | 0.361M |
| Kiora Pharmaceuticals, Inc. | 1.172M |